Lucy White

Lucy is a patent attorney in our Life Sciences team with a strong focus on contentious proceedings involving commercially important patents. She enjoys the strategic and technical demands of complex opposition work, particularly in multi-party oppositions. European litigation forms a substantial part of Lucy’s practice, both defending her clients’ own patents and challenging those of their competitors.

Lucy handles drafting and prosecution alongside her contentious work, bringing a balanced perspective to patent portfolios. Her experience includes delivering large Freedom-to-Operate projects, as well as landscaping and validity analyses.

Areas of Expertise

Lucy’s expertise in biotechnology spans:

• Antibody-based therapeutics (including novel antibody formats and multispecific antibodies)
• Vaccine technology (particularly RNA vaccines)
• Cancer therapeutics
• Immunology and Virology

Clients

Lucy works closely with multinational biopharmaceutical companies, UK universities, IP consultancies and attorney firms to develop clear, practical IP strategies that support business objectives.

Background

Lucy holds a B.A. in Natural Sciences from the University of Cambridge, specialising in Pathology. Her undergraduate research focused on immune evasion during human cytomegalovirus infection.

Lucy joined Mewburn Ellis LLP in 2019 and qualified as a European and Chartered Patent Attorney in 2023.